Answers are grounded in this paper and cite their sources.
Objective Continuous glucose monitors (CGMs) enhance diabetes management, but disparities exist, particularly among underserved populations in federally qualified health centers (FQHCs). In 2022, a California Medicaid policy change expanded CGM coverage, providing an opportunity to better evaluate barriers to CGM use within primary care in an FQHC. Methods We used 2022–2023 electronic health record (EHR) data to identify adults with diabetes managed on insulin within a nurse practitioner–led diabetes program in primary care. Patients were categorized as current, former, or never CGM users. We used summary statistics, chi‐squared, and Bartlett′s tests to assess unadjusted group differences and multivariate logistic regression to identify factors associated with former or never use. All patients were invited to complete a survey on CGM facilitators and barriers. Results Among 275 eligible patients, 109 (40%) were current CGM users, 31 (11%) former users, and 135 (49%) never users. Discussions on CGM occurred in 45% of never users, who were more likely to have non‐Medicaid insurance, fewer than five clinic visits (OR 3.69, 95% CI: 1.94–6.99), and a lower baseline A1C (OR 0.67, 95% CI: 0.52–0.86). No demographic or clinical factors were associated with former CGM use. Among survey respondents ( n = 124), the desire to reduce finger‐pricks motivated CGM use, while device burden and inconvenience contributed to discontinuation or refusal. Conclusions Medicaid policy expansion reduced major structural barriers to CGM use, yet some patient‐related barriers persisted. Team‐based care models integrating health educators and advanced practice providers can successfully support CGM access and sustained use in underserved populations.
No takes yet. Share an insight, caveat, or question.
Scarlett et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: